Orsiro | 合法醫療器材資訊網

1.KandzariDetal.Ultrathin,bioresorbablepolymersirolimus-elutingstentsversusthin,durablepolymereverolimuselutingstentsinpatientsundergoing ...

Orsiro®

Ultrathin struts§. Outstanding patient outcomes◊.

Outstanding patient outcomes

Improving patient outcomes, year after year*

BIOFLOW-V (n = 1,334) the FDA pivotal trial

Significant differences in TLF observed at year 1 and 2 were maintained and further increased at year 3 (8.6% vs. 14.4%, p = 0.003), driven by significant differences in TV-MI (5.5% vs. 10.1%, p = 0.004) and Ischemiadriven TLR (3.4% vs. 6.9%, p = 0.008) that...